Pharmacogenomic Medicine in Autism: Challenges and Opportunities

Glix 13, a New Drug Acting on Glutamatergic Pathways in Children and Animal Models of Autism Spectrum Disorders

(2014) Annamaria Chiara Santini et al.   Biomed Research International

Five-Fold Increase in National Prevalence Rates of Attention-Deficit/Hyperactivity Disorder Medications for Children and Adolescents with Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and other Psychiatric Disorders: A Danish Register-Based Study

(2013) Søren Dalsgaard et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Drug discovery for autism spectrum disorder: challenges and opportunities

(2013) Anirvan Ghosh et al.   NATURE REVIEWS DRUG DISCOVERY

The effect of the Taq1A variant in the dopamine D2 receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys

(2013) Yvette Roke et al.   Pharmacogenetics and Genomics

Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies

(2013) E L Nurmi et al.   Translational Psychiatry

Cluster Analysis of Autistic Patients Based on Principal Pathogenetic Components

(2012) Roberto Sacco et al.   Autism Research

Shared Synaptic Pathophysiology in Syndromic and Nonsyndromic Rodent Models of Autism

(2012) S. J. Baudouin et al.   SCIENCE

Pathways to Drug Development for Autism Spectrum Disorders

(2011) D R Hampson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism

(2011) Joseph R. Moskal et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Gene expression in blood is associated with risperidone response in children with autism spectrum disorders

(2011) L Lit et al.   PHARMACOGENOMICS JOURNAL

Pharmacologic Treatment of Behavioral Symptoms Associated With Autism and Other Pervasive Developmental Disorders

(2010) Logan K. Wink et al.   Current Treatment Options in Neurology

Risperidone-Induced Weight Gain in Referred Children with Autism Spectrum Disorders Is Associated with a Common Polymorphism in the 5-Hydroxytryptamine 2C Receptor Gene

(2010) Pieter J. Hoekstra et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Clinical Genetic Testing for Patients With Autism Spectrum Disorders

(2010) Y. Shen et al.   PEDIATRICS

Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk

(2009) Maurizio Pompili et al.   Expert Review of Neurotherapeutics

Aripiprazole in Pervasive Developmental Disorder Not Otherwise Specified and Asperger's Disorder: A 14-Week, Prospective, Open-Label Study

(2009) Kimberly A. Stigler et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Phenomic determinants of genomic variation in autism spectrum disorders

(2009) Y Qiao et al.   JOURNAL OF MEDICAL GENETICS

Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions

(2009) C T Correia et al.   PHARMACOGENOMICS JOURNAL